Clinical Trial Update: Cutaneous Lupus Erythematosus and Elidel [NA]

View source ↗

Summary

A clinical trial investigating Elidel (pimecrolimus) for cutaneous lupus erythematosus and discoid lupus erythematosus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus
• Discoid Lupus Erythematosus

Drugs mentioned

• Elidel (pimecrolimus)

Snippet

Sponsor: University of Leipzig | Conditions: Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid | NA | Status: WITHDRAWN